Good Medicine Podcast

Good Medicine Podcast

The science behind what makes medicine...good

  1. 6d ago

    The Truth About Energy Drinks | Dr. Brian Parker

    Energy drinks have a bad reputation. But are they actually bad for you? In this episode of the Good Medicine Podcast, Dr. Jeremiah Bearss sits down with internal medicine physician Dr. Brian Parker to separate what we know about energy drinks and caffeine from what gets repeated online. They discuss how the shift toward sugar-free energy drinks has changed the conversation, what caffeine actually does to the body, and why the popular advice to wait 60 to 90 minutes after waking before consuming caffeine isn't as scientifically established as social media might make it seem. Dr. Parker also explains why caffeine can be a useful tool when used intelligently, while still being a poor substitute for addressing the reasons you're tired in the first place. The answer to whether energy drinks are "good" or "bad" turns out to be a lot more nuanced than the label on the can. Topics covered include: • Are energy drinks actually unhealthy? • Sugar-free vs. traditional energy drinks • Caffeine and its effects on the body • Should you wait 60 to 90 minutes for your morning caffeine?• When caffeine can actually be useful • Using caffeine without relying on it for energy 🎧 Listen on Spotify and Apple Podcasts 📺 Subscribe for more conversations on science, medicine, and health. Thank you to our sponsors BioHive: https://www.biohive.com Galvan: https://galvan.sng.link/D4mh8/oe8k/littFollow Good Medicine Podcast Insta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

    The Truth About Energy Drinks | Dr. Brian Parker
  2. Sep 1

    The New Cancer Vaccine Results Are a Big Deal| Dr. David & Jeremiah Bearss

    Moderna and Merck just announced major Phase 3 results for their personalized mRNA cancer vaccine. In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss break down the newly announced results from the Phase 3 INTerpath-001 trial in patients with high-risk melanoma. The trial met both of its primary endpoints, showing improvement in recurrence-free survival and distant metastasis-free survival when the individualized therapy was combined with Keytruda. Dave and JJ explain why seeing an effect across both measures is significant, what makes a therapeutic cancer vaccine different from the vaccines most people are familiar with, and why these results could represent an important step toward personalized cancer vaccines becoming part of cancer treatment. They also discuss what still needs to happen, who may ultimately benefit from this type of therapy, and why Dave believes there is a real clinical signal in the data. Topics covered include: • Moderna and Merck's new Phase 3 cancer vaccine results • How personalized mRNA cancer vaccines work • Therapeutic vaccines vs. traditional vaccines • Recurrence and distant metastasis in melanoma • What these results could mean for future cancer treatment 🎧 Listen on Spotify and Apple Podcasts 📺 Subscribe for more conversations on science, medicine, and innovation. Thank you to our sponsors BioHive: https://www.biohive.com Galvan: https://galvan.sng.link/D4mh8/oe8k/litt Follow Good Medicine Podcast Insta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

    The New Cancer Vaccine Results Are a Big Deal| Dr. David & Jeremiah Bearss
  3. Aug 4

    The Future of Drug Discovery | Dr. Hari Vankayalapati

    Drug discovery has changed dramatically over the past few decades. In this episode of the Good Medicine Podcast, Dr. David Bearss and Dr. Jeremiah Bearss sit down with longtime colleague Dr. Hari Vankayalapati to discuss how the field has evolved and where it's headed next. Together, they reflect on lessons learned throughout their careers, including a philosophy that has shaped their approach to developing new medicines: start with the end goal and work backward from the clinical trial needed for approval. They also explore how artificial intelligence is transforming research by accelerating discovery, reducing cost, and helping scientists analyze data more efficiently. But while AI is becoming an increasingly valuable tool, they explain why human judgment remains essential to making the right scientific decisions. Topics covered include: • How AI is changing modern drug discovery • Why successful drug development starts with the end in mind • Why scientists remain essential in the age of AI 🎧 Listen on Spotify and Apple Podcasts📺 Subscribe for more conversations on science, medicine, and innovation. Thank you to our sponsors BioHive: https://www.biohive.com Galvan: https://galvan.sng.link/D4mh8/oe8k/litt Follow Good Medicine Podcast Insta: https://www.instagram.com/good.medicine.podcast/ X: https://x.com/GoodMedicinePod TikTok: https://www.tiktok.com/@good.medicine.podcast LinkedIn: https://www.linkedin.com/company/goodmedicinepodcast/

    The Future of Drug Discovery | Dr. Hari Vankayalapati
5
out of 5
9 Ratings

About

The science behind what makes medicine...good

You Might Also Like